Orexigen Therapeutics (OREX) Tops Q3 EPS by 78c, Miss on Revenues
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q3 EPS of ($1.35), $0.78 better than the analyst estimate of ($2.13). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $24.2 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
